Small bowel review: diseases of the small intestine.
In the past year there have been many advances in the area of small bowel physiology and pathology and therapy. In preparation for this review, over 1500 papers were assessed. The focus is on presenting clinically useful information for the practicing gastroenterologist. Selected important clinical learning points include the following: (1) glutamine may restore the AIDs-associated increased intestinal permeability to normal; (2) substance P is a major mediator of diarrhea caused by Costridium difficile toxin A, acting by binding to a G-protein-coupled receptor, and represents a possible 2therapeutic target; (3) the serological diagnosis of celiac disease has been greatly enhanced with the use of anti-endomysial antibody testing, and the recent antitransglutaminase; (4) a quarter of patients with celiac disease may have secondary pancreatic insufficiency and require enzyme replacement therapy; (5) in the patient with unexplained elevation in the serum transaminase concentration, consider celiac disease as an obscure possibility; (6) bosentan and endothelin receptor agonist may prove to be useful in reducing gut ischemia in patients with septic shock; and (7) the administration of recombinant human fibroblast growth factor-2 may prove to be useful to prevent radiation damage to the gastrointestinal tract.
Thomson
A B
AB
Department of Medicine, University of Alberta, Edmonton, Canada.
Keelan
M
M
Thiesen
A
A
Clandinin
M T
MT
Ropeleski
M
M
Wild
G E
GE
D000375:Aging; D000818:Animals; D002446:Celiac Disease / Q000175:diagnosis / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000503:physiopathology; D004761:Enterocolitis, Pseudomembranous; D004927:Escherichia coli Infections; D006801:Humans; D007410:Intestinal Diseases / Q000175:diagnosis / Q000382:microbiology / Q000503:physiopathology; D007421:Intestine, Small / Q000098:blood supply / Q000528:radiation effects; D015427:Reperfusion Injury / Q000503:physiopathology